What is ALKS's P/E ratio?

ALKERMES PLC (ALKS) currently trades at a P/E ratio of 32.99.

ALKERMES PLC reports a Return on Equity (ROE) of 8.72%.

What is ALKS's dividend yield?

ALKERMES PLC offers a dividend yield of 0.00%.

What is ALKS's Deepscope Quality Score?

Deepscope rates ALKS's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ALKS?

Deepscope's AI Timing Score for ALKS is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ALKS belong to?

ALKERMES PLC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

Cổ phiếu ALKS (NASDAQ) | ALKERMES PLC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

ALKS

ALKERMES PLC

USD 42.80

-0.58 (-1.34%) Day Change

Watchlist Portfolio Compare Chart

32.99

P/E

0.87

D/E

8.7%

ROE

3.6%

ROA

0.00%

Div Yield

-0.28

PEG

ALKERMES PLC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 42.80 Price -0.58 (-1.34%) Day Change	NEWS SCORE: 58

ALKS Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	58
Magic Formula Rank by ROA	1430
Magic Formula Rank by ROE	1430
Magic Formula Rank by ROIC	1092
Price	42.80
PBV / Sector	4.13 / 2.76
Earning Per Share	0.90

PE / Sector	32.99 / 23.64
PEG or PE/Growth / Sector	-0.28 / 0.13
Average 1M Daily Value	81.65 M
Average 1W Daily Value	84.05 M

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

58%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	9.78 / 15.98
NPM Average (%) / Sector	11.37 / -16.38 GOOD
NPM Change Average (%) / Sector	-77.72 / 113.39
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	3.59 / 8.16
ROA Average (%) / Sector	7.92 / 2.38
ROA Change Average (%) / Sector	-102.10 / 108.63
ROE (%) / Sector	8.72 / -0.19
ROE Average (%) / Sector	12.30 / 7.40
ROE Change Average (%) / Sector	-97.93 / 371.95
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.53
Dividend Average (%) / Sector	N/A / 3.08
Dividend Change Average (%) / Sector	N/A / 14.88

Chi tiết đăng ký

Analyze Date	2026-06-06 09:08:26
Symbol	ALKS
Name	ALKERMES PLC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	166.68 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	7,230.40 / 9,835.56

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Connaught House, Dublin, Ireland, D04 C5Y6

Phone: 353 1 772 8000

Website: https://www.alkermes.com

Employees: 2,050

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.